Loading clinical trials...
Loading clinical trials...
Next generation sequencing (NGS) allows some better diagnostic results, particularly, in the rare diseases field. At a twenty five percent rate, those exams highlight some variants which are not yet d...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University Hospital, Angers
NCT06672237 · Neuromuscular Disease, Neuromuscular Diseases (NMD), and more
NCT07527624 · Rare Diseases
NCT06595940 · Undiagnosed Diseases, Rare Diseases
NCT07247279 · Rare Diseases, Generalized Myasthenia Gravis (gMG)
NCT07040774 · Genetic Disease, Immune Dysfunction, and more
Centre Hospitalo-Universitaire d'Angers
Angers
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions